VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system
Author:
Funder
National Cancer Institute
Austrian Science Fund
National Institutes of Health
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Link
https://insight.jci.org/articles/view/158755/files/pdf
Reference52 articles.
1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014;Ostrom;Neuro Oncol,2017
2. Neuroblastoma
3. Management of glioblastoma: State of the art and future directions
4. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
5. Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Methylation synthetic lethality: Exploiting selective drug targets for cancer therapy;Cancer Letters;2024-08
2. Novel Dihydropteridinone Derivatives As Potent Inhibitors of the Understudied Human Kinases Vaccinia-Related Kinase 1 and Casein Kinase 1δ/ε;Journal of Medicinal Chemistry;2024-05-23
3. Nuclear functions regulated by the VRK1 kinase;Nucleus;2024-05-16
4. Developmental origins shape the paediatric cancer genome;Nature Reviews Cancer;2024-05-02
5. VRK1 promotes DNA-induced type I interferon production;Molecular Biology Reports;2024-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3